SelectScience InterviewsLife Sciences
Developing Flavivirus Vaccines with Multiplexed Immunogenicity Screening
17 Dec 2018
Flaviviruses are a group of single-stranded RNA species that present an unmet clinical need for vaccines. Listen to Eric Shaw, of Takeda Vaccines, discuss his company’s efforts in developing multiplexed FLAVI screening assays, with 13 different antigens spanning seven different species, to advance research and development in the field.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
